Microsalt Regulatory News (SALT)

6 March 2024

MicroSalt plc

("MicroSalt" or the "Company")

Intellectual Property ("IP") Update

MicroSalt plc, (AIM: SALT) a company producing full-flavour, low-sodium salt for food manufacturers and consumers, is pleased to announce that it has received a Notice of Allowance from the United States Patent and Trademark Office for Patent Application No. 18/175,028.

The Patent Application entitled Low Sodium Salt Composition, concerns the production of MicroSalt, a low-sodium salt that adheres better to foods than a traditional salt (which is not adhered to a carrier particle).

Receipt of a Notice of Allowance indicates that the claims in the patent application are patentable. MicroSalt expect the patent will be granted upon completion of certain administrative matters in short course. Once granted, the patent is expected to expire in 2039.

This Notice of Allowance relates to one of the 14 pending patent applications described in the Company's admission document dated 27 January 2024. MicroSalt also has counterpart patent applications with claims directed to similar subject matter as the Patent Application 18/175,028 pending in countries including China, Chile, Australia, Brazil, Europe, Canada, Japan, Russia, Mexico, India and Hong Kong.

MicroSalt also owns a previously issued United States patent directed to its salt carrier product and production processes, and a United States provisional patent application directed to additional innovations.

Rick Guiney, CEO of Microsalt, said:

"This Notice of Allowance further strengthens our IP position in the global low sodium market whilst providing additional evidence of our thought leadership position in the battle to lower sodium consumption worldwide."

 For more information, please visit www.microsaltinc.co, follow on X @microSaltPLC or contact:

Notes to Editors

MicroSalt® produces a patented full-flavour, low-sodium salt for food manufacturers and consumers.

MicroSalt is a major potential disruptor in the food market, thanks to its micron sized particles which deliver the same sense of saltiness to a wide range of foods but with approximately 50% less sodium. Excess sodium consumption is a significant contributor to cardiovascular disease and MicroSalt's solution meets the rising demand for healthier alternatives to traditional salt. The WHO has set a target for reducing global sodium intake by 30% by 2025, which it estimates will save 7 million lives by 2030.

Each year, cardiovascular disease costs the UK £19 billion - if the average salt intake was reduced by one gram per day, it has been estimated that 4,147 lives and £288 million would be saved each year in the UK. As a nation, the UK consumes 183 million kilograms of salt each year, and 70% of the typical person's sodium intake is hidden in processed foods.

Operational since 2018, MicroSalt uses a patent-protected technology which helps create high barriers to entry within the reduced-sodium salt market.

The Directors believe that MicroSalt is well positioned to capture growth in the low sodium market, which is expected to grow exponentially, and that there is also scope to enter the larger salt market.

ENDS